Ann Rehabil Med.  2012 Apr;36(2):254-261. 10.5535/arm.2012.36.2.254.

Impact of Exercise-based Cardiac Rehabilitation on In-stent Restenosis with Different Generations of Drug Eluting Stent

• Kim C
• Choi HE
• Kim BO
• Lim MH

• KMID: 2266765
• DOI: http://doi.org/10.5535/arm.2012.36.2.254

Abstract

OBJECTIVE
To compare the rate of restenosis between a cardiac rehabilitation (CR) group and a control group within three different generations of drug eluting stents (DES). METHOD: Patients who received DES due to an acute coronary syndrome were included. They were divided into a CR group and a control group. The CR group received six to eight weeks of early cardiac rehabilitation program in a hospital setting, and sustained a self-exercise program for six months in a community. The control group was instructed to exercise by themselves after leaving the hospital. Nine months after the first onset of disease, we implemented a coronary angiography and compared the two groups. In addition, we divided the patients into three subgroups according to the generation of DES, and compared the rate of restenosis between the CR group and control group within these three subgroups.
RESULTS
At 9 months, in-stent restenosis, measured as an in-segment late luminal loss (LLL) of the stented coronary area, was smaller in the CR group (n=52) 0.16+/-0.42 mm compared to the control group (n=51) 0.39+/-0.78 mm (p<0.05). A reduction of LLL in the CR group compared to the control group was consistent among the three different generations of DES.
CONCLUSION
The CR program is strongly associated with a significant reduction in LLL in the stented coronary segments, regardless of the generation of DES.

Keyword

Coronary restenosis; Drug eluting stent; Exercise; Rehabilitation

MeSH Terms

Acute Coronary Syndrome
Coronary Angiography
Coronary Restenosis
Drug-Eluting Stents
Family Characteristics
Humans
Phenobarbital
Stents
Phenobarbital

Reference

1. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004; 116:682–692. PMID: 15121495.

2. Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004; 328:189. PMID: 14729656.

3. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens CH. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989; 80:234–244. PMID: 2665973.

4. Dugmore LD, Tipson RJ, Phillips MH, Flint EJ, Stentiford NH, Bone MF, Littler WA. Changes in cardiopulmonary fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme. Heart. 1999; 81:359–366. PMID: 10092561.

5. Witt BJ, Jacobsen SJ, Weston SA, Killian JM, Meverden RA, Allison TG, Reeder GS, Roger VL. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol. 2004; 44:988–996. PMID: 15337208.

6. Niebauer J, Hambrecht R, Velich T, Hauer K, Marburger C, Kalberer B, Weiss C, von Hodenberg E, Schlierf G, Schuler G, et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation. 1997; 96:2534–2541. PMID: 9355890.

7. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone LM, Champagne MA, Krauss RM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994; 89:975–999. PMID: 8124838.

8. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361:13–20. PMID: 12517460.

9. Cannan CR, Yeh W, Kelsey SF, Cohen HA, Detre K, Williams DO. Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Am J Cardiol. 1999; 84:170–175. PMID: 10426335.

10. Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, et al. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angioplasty (PASEO) randomized trial. Am Heart J. 2009; 158:e43–e50. PMID: 19781402.

11. Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database Syst Rev. 2010; 5:CD004587. PMID: 20464732.

12. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346:1773–1780. PMID: 12050336.

13. Zeiher AM, Drexler H, Wollschlaeger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991; 84:1984–1992. PMID: 1934373.

14. Post MJ, de Smet BJ, van der Helm Y, Borst C, Kuntz RE. Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. Circulation. 1997; 96:996–1003. PMID: 9264511.

15. Wentzel JJ, Krams R, Schuurbiers JC, Oomen JA, Kloet J, van Der Giessen WJ, Serruys PW, Slager CJ. Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation. 2001; 103:1740–1745. PMID: 11282904.

16. Saleh N, Tornvall P. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis. 2007; 195:374–378. PMID: 17126343.

17. Piatti P, Di Mario C, Monti LD, Fragasso G, Sgura F, Caumo A, Setola E, Lucotti P, Galluccio E, Ronchi C, et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation. 2003; 108:2074–2081. PMID: 14530196.

18. Munk PS, Staal EM, Butt N, Isaksen K, Larsen AI. High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation. A randomized controlled trial evaluating the relationship to endothelial function and inflammation. Am Heart J. 2009; 158:734–741. PMID: 19853690.

19. Walther C, Mobius-Winklera S, Linke A, Bruegel M, Thiery J, Schuler G, Halbrecht R. Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil. 2008; 15:107–112. PMID: 18277195.

20. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol. 2001; 37:1891–1900. PMID: 11401128.

21. Kim C, Lim HS, Ahn JK, Bang IK, Lee SM, Kim YJ. The reasons that cardiac patients did not participate in and drop out from the cardiac rehabilitation program. J Korean Acad Rehabil Med. 2002; 26:790–796.

22. Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E, Walther T, Mohr FW, Schuler G, Falk V. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol. 2009; 53:2324–2331. PMID: 19539141.

23. Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med. 2002; 162:2405–2410. PMID: 12437397.

24. The World Health Report 1997- conquering suffering, enriching humanity. World Health Forum. 1997; 18:248–260. PMID: 9478137.

25. Brezinka V, Kittel F. Psychosocial factors of coronary heart disease in women: a review. Soc Sci Med. 1996; 42:1351–1365. PMID: 8735892.

26. Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary angioplasty versus surgical revascularization) registry. J Am Coll Cardiol. 2009; 54:853–859. PMID: 19695467.

27. Izawa K, Hirano Y, Yamada S, Oka K, Omiya K, Iijima S. Improvement in physiological outcomes and health-related quality of life following cardiac rehabilitation in patients with acute myocardial infarction. Circ J. 2004; 68:315–320. PMID: 15056827.

28. Wernick MH, Jeremias A, Carrozza JP. Drug-eluting stents and stent thrombosis: a cause for concern? Coron Artery Dis. 2006; 17:661–665. PMID: 17119373.

29. Lemesle G, Delhaye C, Bonello L, de Labriolle A, Waksman R, Pichard A. Stent thrombosis in 2008: definition, predictors, prognosis and treatment. Arch Cardiovasc Dis. 2008; 101:769–777. PMID: 19059572.

30. Dos Santos A, Peirano JD, Bastianello MJ, Calvino RO. Very late drug-eluting stent thrombosis post-exercise myocardial perfusion SPECT. J Nucl Cardiol. 2010; 17:928–933. PMID: 20151237.

31. Lan C, Chen SY, Chiu SF, Hsu CJ, Lai JS, Kuan PL. Poor functional recovery may indicate restenosis in patients after coronary angioplasty. Arch Phys Med Rehabil. 2003; 84:1023–1027. PMID: 12881828.